Loop Industries, Inc. (LOOP) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-05-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-05-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-05-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 3.17M USD | Research and Development Expense |
| Revenue | (m) | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 2.06M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $3.17M | (m) | $2.06M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-02-28 | $3.47M | $514.00K | $1.45M | (m) | (m) | 675.49% | 282.68% | (m) | (m) |
| 2025-11-30 | $4.49M | (m) | $1.26M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-08-31 | $4.90M | $11.11M | $1.27M | (m) | (m) | 44.09% | 11.47% | (m) | (m) |
| 2025-05-31 | $6.00M | $11.13M | $1.36M | (m) | (m) | 53.89% | 12.19% | (m) | (m) |
| 2025-02-28 | $6.86M | $10.89M | $1.35M | (m) | (m) | 63.04% | 12.42% | (m) | (m) |
| 2024-11-30 | $8.58M | $126.00K | $1.34M | (m) | (m) | 6807.14% | 1066.67% | (m) | (m) |
| 2024-08-31 | $9.03M | $101.00K | $1.41M | (m) | (m) | 8943.56% | 1397.03% | (m) | (m) |
| 2024-05-31 | $9.13M | $132.00K | $1.44M | (m) | (m) | 6913.64% | 1088.64% | (m) | (m) |
| 2024-02-29 | $11.38M | $153.00K | $1.42M | (m) | (m) | 7437.25% | 929.41% | (m) | (m) |
| 2023-11-30 | $10.57M | $120.84K | $1.26M | (m) | (m) | 8750.53% | 1040.39% | (m) | (m) |
| 2023-08-31 | $13.32M | $118.84K | $1.73M | (m) | (m) | 11210.19% | 1459.29% | (m) | (m) |
| 2023-05-31 | $15.04M | $199.84K | $1.98M | (m) | (m) | 7524.08% | 988.39% | (m) | (m) |
| 2023-02-28 | $17.35M | $172.84K | $10.09M | (m) | (m) | 10035.97% | 5835.63% | (m) | (m) |
| 2022-11-30 | $22.11M | $160.35K | $10.67M | (m) | (m) | 13789.46% | 6653.97% | (m) | (m) |
| 2022-08-31 | $24.37M | $135.43K | $10.44M | (m) | (m) | 17991.43% | 7707.14% | (m) | (m) |
| 2022-05-31 | $25.90M | $0.00 | $10.51M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-04 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-02 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-02-28 | $27.74M | $0.00 | $2.06M | (m) | $154.32K | (m) | (m) | (m) | Reported |
| 2021-11-30 | $28.94M | $0.00 | $2.26M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-08-31 | $32.34M | $0.00 | $2.52M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-05-31 | $25.84M | $0.00 | $2.68M | (m) | $-14.19K | (m) | (m) | (m) | Reported |
| 2021-02-28 | $18.69M | $0.00 | $3.67M | (m) | $82.00K | (m) | (m) | (m) | Reported |
| 2020-11-30 | $11.98M | $0.00 | $3.63M | (m) | $432.23K | (m) | (m) | (m) | Reported |
| 2020-08-31 | $6.98M | $0.00 | $3.61M | (m) | $1.17M | (m) | (m) | (m) | Reported |
| 2020-05-31 | $5.20M | $0.00 | $3.55M | (m) | $1.85M | (m) | (m) | (m) | Reported |
| 2020-02-29 | $4.72M | $0.00 | $3.47M | (m) | $2.22M | (m) | (m) | (m) | Reported |
| 2019-11-30 | $3.77M | $0.00 | (m) | (m) | $2.24M | (m) | (m) | (m) | Reported |
| 2019-08-31 | $3.28M | $0.00 | (m) | (m) | $1.56M | (m) | (m) | (m) | Reported |
| 2019-05-31 | $3.38M | $0.00 | (m) | (m) | $956.02K | (m) | (m) | (m) | Reported |
| 2019-02-28 | $3.45M | $0.00 | (m) | (m) | $467.08K | (m) | (m) | (m) | Reported |
| 2018-11-30 | $4.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-08-31 | $7.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-05-31 | $7.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-02-28 | $6.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-11-30 | $5.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-08-31 | $2.05M | (m) | (m) | $-3.33M | (m) | (m) | (m) | (m) | (m) |
| 2017-05-31 | $1.54M | (m) | (m) | $-8.26M | (m) | (m) | (m) | (m) | (m) |
| 2017-02-28 | $1.45M | (m) | (m) | $-8.81M | (m) | (m) | (m) | (m) | (m) |
| 2016-11-30 | $1.52M | (m) | (m) | $-3.57M | (m) | (m) | (m) | (m) | (m) |
| 2016-08-31 | $1.39M | (m) | (m) | $-3.56M | (m) | (m) | (m) | (m) | (m) |
| 2016-05-31 | $1.21M | (m) | (m) | $-3.46M | (m) | (m) | (m) | (m) | (m) |
| 2016-02-29 | $801.67K | (m) | (m) | $-2.84M | (m) | (m) | (m) | (m) | (m) |
| 2015-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-08-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-05-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-02-28 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GULF RESOURCES, INC. (GURE) | $0.006B | ||
| CitroTech Inc. (CITR) | United States | $0.097B | -5.12 |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |